Cessation of dexamethasone exacerbates airway responses to methacholine in asthmatic mice

Area of Science:

• Immunology
• Pulmonology
• Pharmacology

Background:

• Asthma is a chronic respiratory disease characterized by airway inflammation and hyperresponsiveness.
• Corticosteroids like dexamethasone are commonly used to manage asthma symptoms.
• The long-term effects of dexamethasone cessation on asthma exacerbations require further investigation.

Purpose of the Study:

• To investigate the effects of dexamethasone treatment and subsequent withdrawal on airway inflammation and hyperresponsiveness in a mouse model of asthma.
• To determine the role of eosinophils and neutrophils in the observed changes.

Main Methods:

• Ovalbumin-induced asthma model in mice.
• Oral administration of dexamethasone or vehicle.
• Exposure to ovalbumin aerosols.
• Assessment of methacholine-induced airway hyperresponsiveness (pulmonary gas trapping).
• Analysis of bronchoalveolar lavage fluid for inflammatory cell counts (eosinophils, neutrophils).

Main Results:

• Dexamethasone treatment reduced methacholine-induced pulmonary gas trapping and inhibited eosinophils and neutrophils.
• Five days after dexamethasone cessation, airway obstruction was exacerbated in treated mice compared to controls.
• Eosinophils remained inhibited, but neutrophils did not, after dexamethasone withdrawal.
• Worsened airway obstruction occurred in the absence of significant eosinophilic airway inflammation.

Conclusions:

• Dexamethasone withdrawal can paradoxically worsen airway obstruction in asthma, independent of eosinophilic inflammation.
• The findings highlight potential risks associated with corticosteroid cessation in asthma management.
• Further research is needed to understand the mechanisms underlying steroid withdrawal-induced airway hyperresponsiveness.